Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
about
Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adultsThe APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and miceIndividual estimates of age at detectable amyloid onset for risk factor assessment.Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.What is Normal Cognitive Aging? Evidence from Task-Based Functional Neuroimaging.Strategies for Preventing Cognitive Decline in Healthy Older Adults.Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.1H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults.Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years PriorCognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease.Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.APOE genotype and early β-amyloid accumulation in older adults without dementia.Personality Change in the Preclinical Phase of Alzheimer Disease.Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content.Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ɛ4 genotype.A Specific Reduction in Aβ1-42 vs. a Universal Loss of Aβ Peptides in CSF Differentiates Alzheimer's Disease From Meningitis and Multiple Sclerosis.
P2860
Q33868184-5C1CFC24-B75D-4630-BA1B-E95CA4580037Q36393038-EA9B49CA-E5A8-4BC0-8D70-91A747B95CE2Q36827330-E432DC0A-3775-45F1-897B-8A658CA23BD5Q36944745-2354EE71-76E8-4E04-85CE-92E70B3272CBQ37100074-98977EBC-A909-4267-8239-803065550446Q37520832-F00AD81E-CBC9-499F-8629-23FE456BC8D6Q38632396-077058FB-2E2E-4DBC-BCF4-D59D1EDB63F4Q39432214-154B12E5-C560-447C-A319-F9CE437AAA8AQ39929112-465AD0F6-3AAF-4E59-BFCF-DAB9B3159A80Q42665050-30E26895-D892-4198-B632-36D098F1A305Q42858923-D07F9F49-E95C-4A56-A8A1-BB2044E0AF9FQ47610192-297B3154-DF6B-43C4-B83E-AF6D363C7EAFQ47625969-F6A8D781-A3E6-48FD-878D-5FC4B97FD049Q47650724-26C571E7-D376-4EB0-A8CD-6DACF794FB3FQ47662540-133ECCF7-C867-462E-8E8F-943603F55F0BQ47842309-3605008F-BDE0-4A93-B5C6-8EF3C61164DAQ52572998-0947451E-DE49-42FB-B961-3EBEEF48D4D0Q53397288-C557271A-C5F8-4DDC-9A73-F0035AF12F81Q55002822-868639CE-994D-4F20-8401-07FDBD8BD71F
P2860
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 April 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
@en
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
@nl
type
label
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
@en
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
@nl
prefLabel
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
@en
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
@nl
P2093
P2860
P50
P1476
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
@en
P2093
Abhay Moghekar
Dean F Wong
Jerry L Prince
Luigi Ferrucci
Marilyn S Albert
Mei-Cheng Wang
Richard J O'Brien
Susan M Resnick
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2015.04.001
P577
2015-04-04T00:00:00Z